Adamas Pharmaceuticals Inc 4
4 · Adamas Pharmaceuticals Inc · Filed May 5, 2017
Insider Transaction Report
Form 4
KING RICHARD
Chief Operating Officer
Transactions
- Award
Common Stock
2017-05-05+28,125→ 28,125 total - Award
Stock Option (Right to Buy)
2017-05-05+168,750→ 168,750 totalExercise: $17.40Exp: 2027-05-04→ Common Stock (168,750 underlying)
Footnotes (2)
- [F1]Represents the grant of restricted stock units that vest 1/4th on each of June 20, 2018, June 20, 2019, June 20, 2020, and June 20, 2021.
- [F2]The shares subject to the option shall become vested according to the following schedule: 25% of the shares subject to the option shall vest on April 28, 2018, and the remaining shares will vest in equal monthly installments over the next 36 months.